| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $889.8M | +23.0% |
| Cost of Revenue | $704.2M | +29.5% |
| R&D Expense | $3.8M | +137.5% |
| SG&A Expense | $178.5M | +15.3% |
| Operating Income | -$4.2M | -120.1% |
| Interest Expense | $45.0M | +14.2% |
| Pre-tax Income | -$15.5M | -152.9% |
| Income Tax | $11.1M | +597.4% |
| Net Income | -$22.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.7M | -65.9% |
| Accounts Receivable | $162.5M | +23.0% |
| Inventory | $102.6M | +29.1% |
| Current Assets | $557.6M | -4.3% |
| Total Assets | $942.7M | +3.2% |
| Current Liabilities | $372.0M | +46.8% |
| Total Liabilities | $944.7M | +10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.6M | +72.4% |
| Capital Expenditures | $13.2M | +98.2% |
| Investing Cash Flow | -$68.8M | -105.1% |
| Financing Cash Flow | -$11.2M | -103.7% |
| Free Cash Flow | -$43.9M | +62.8% |
| -174.0% |
| EPS (Basic) | -$0.43 | -265.4% |
| EPS (Diluted) | -$0.43 | -265.4% |
| Stockholders' Equity |
| -$2.6M |
| -107.8% |